For the Inventor, By the Inventor

Enter assignee name

Monmouth Junction, NJ, United States of America

Tris Pharma, Inc.

USPTO Granted Patents = 58

% Expired Patents = 5.2

CIPO Patents = 2

EPO Patents = 6

Trademarks = 11

Forward Citations = 2,276

Loading Chart...

Loading Chart...

19 inventors (with patents filed for the assignee):

Yu-Hsing Tu (44 out of 53 patents)

Ketan Mehta (32 out of 32 patents)

Ashok Perumal (18 out of 27 patents)

4. Kalyan Kathala (16 out of 28 patents)

5. Paras Rameshlal Jain (7 out of 7 patents)

6. Sachin Vasant Chaudhari (7 out of 7 patents)

7. Andrea Nelson (6 out of 6 patents)

8. Quin-Zene Chen (5 out of 5 patents)

9. Harsh Mehta (5 out of 5 patents)

10. Mahendra Shah (2 out of 2 patents)

11. Grishma Patel (2 out of 2 patents)

12. Alivia Chaudhuri (1 out of 1 patent)

13. Nemichand B Jain (1 out of 16 patents)

14. Shivanand Puthli (1 out of 1 patent)

15. Mahesh Chavan Patil (1 out of 1 patent)

Core Competencies:

Extended Release Tablets

Gastro-Retentive Systems

Modified Release Formulations

Drug-Ion Exchange Resin

Methylphenidate Compositions

Benzonatate Tablets

Clonidine Formulations

GHB Pharmaceutical Compositions

Floating Polymer Networks

Trigger Pulse Drug Release

Chewable Tablets

Aqueous Suspension Products

58 patents: Sort by Forward Citations

1. 12734132 - Extended release amphetamine tablets (2026-09-15),

2. 12605333 - Modified release drug powder composition comprising gastro-retentive raft forming systems having trigger pulse drug release (2026-04-21),

3. 12576032 - Liquid clonidine extended release composition (2026-03-17),

4. 12533314 - Low sodium oxybate once nightly composition (2026-01-27),

5. 12514818 - Pharmaceutical compositions comprising a floating interpenetrating polymer network forming system (2026-01-06),

6. 12458592 - Extended release amphetamine tablets (2025-11-04),

7. 12201720 - Pharmaceutical composition comprising GHB gastro-retentive raft forming systems having trigger pulse drug release (2025-01-21),

8. 12076441 - Extended release amphetamine tablets (2024-09-03),

9. 11938224 - Benzonatate modified release solid tablets and capsules (2024-03-26),

10. 11918689 - Liquid clonidine extended release composition (2024-03-05),

11. 11890267 - Benzonatate modified release solid tablets and capsules (2024-02-06),

12. 11666546 - GHB pharmaceutical compositions comprising a floating interpenetrating polymer network forming system (2023-06-06),

13. 11633389 - Methylphenidate extended release chewable tablet (2023-04-25),

14. 11590228 - Extended release amphetamine compositions (2023-02-28),

15. 11590081 - Extended release amphetamine tablets (2023-02-28),

Tris Pharma, Inc. is a pharmaceutical company that specializes in developing and manufacturing innovative solutions for patients. With a focus on drug delivery technology, Tris Pharma aims to improve the effectiveness and convenience of medication for better patient outcomes. The company offers a wide range of products across various therapeutic areas and is committed to advancing healthcare through research and development.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

58 Patents

#2 in Monmouth Junction, NJ

#257 in New Jersey

#6,138 in US

#12,356 in the World

Monmouth Junction, NJ, United States of America

Tris Pharma, Inc.

Forward Citations = 2,276

19 inventors:

Yu-Hsing Tu (44 out of 53 patents)

Ketan Mehta (32 out of 32 patents)

Ashok Perumal (18 out of 27 patents)

4. Kalyan Kathala (16 out of 28 patents)

5. Paras Rameshlal Jain (7 out of 7 patents)

Please report any incorrect information to [email protected]

Loading…